GNH USA

Europe — EMA

Orotre (Colecalciferol, Calcium Carbonate)

GNH USA supplies Orotre (Colecalciferol), a supplement for vitamin D deficiency, calcium deficiency and bone health support. Request a quote for supply.

Request sourcing

1
Pack/s

What is Colecalciferol, Calcium Carbonate?

Colecalciferol, the active ingredient in Orotre, is a vitamin D3 supplement presented as an oral tablet containing calcium carbonate for combined supplementation. It helps correct vitamin D deficiency and supports calcium homeostasis in individuals at risk of low bone mineral density. The formulation is intended for oral use in adults and children as directed by a healthcare professional.

GNH USA supplies Orotre as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Colecalciferol, Calcium Carbonate used for?

Orotre, containing colecalciferol and calcium carbonate, is used to address disorders of vitamin D and calcium metabolism. - Vitamin D deficiency: restores normal serum 25‑hydroxyvitamin D levels. - Calcium deficiency: provides elemental calcium to support bone health. - Osteoporosis prevention: assists in maintaining bone mineral density in at‑risk populations. - Hypocalcemia: helps raise low blood calcium concentrations.

What are the side effects of Colecalciferol, Calcium Carbonate?

Common Side Effects: - Nausea: mild stomach upset may occur. - Constipation: occasional difficulty passing stool. - Abdominal discomfort: mild cramps or pain. - Headache: transient head pain. - Dry mouth: sensation of oral dryness. - Flatulence: increased gas production.

Serious or Rare Side Effects: - Hypercalcemia: elevated blood calcium levels causing weakness or cardiac arrhythmia. - Kidney stones: formation of calcium‑based calculi in the urinary tract. - Allergic reaction: rash, itching, swelling, or breathing difficulty. - Hypervitaminosis D: toxicity from excessive vitamin D leading to calcification of soft tissues. - Hypercalciuria: excessive urinary calcium excretion increasing renal risk.

What precautions apply to Colecalciferol, Calcium Carbonate?

Before using Orotre, consider the following precautions: - Pregnancy and lactation: consult a healthcare provider before use. - Renal impairment: monitor calcium levels and adjust intake as needed. - Existing hypercalcemia: avoid use if blood calcium is already elevated. - Drug interactions: review all concurrent medications with a professional. - Age considerations: dosage may differ for children and the elderly. - Store at ambient temperature below 25°C: keep in the original pack, protect from moisture and light.

What does Colecalciferol, Calcium Carbonate interact with?

Orotre may interact with several medications. Review the following: Major Interactions (Avoid): - Thiazide diuretics: can increase risk of hypercalcemia. - High-dose vitamin A supplements: may potentiate vitamin D toxicity. - Lithium therapy: may affect calcium metabolism. Moderate Interactions (Monitor Closely): - Oral bisphosphonates: concurrent use may alter calcium balance. - Corticosteroids: may reduce calcium absorption, requiring monitoring. - Antacids containing aluminum or magnesium: can decrease calcium carbonate absorption.

Frequently asked questions

What is Orotre used for?+
Orotre is a combined vitamin D3 (colecalciferol) and calcium carbonate oral tablet used to correct vitamin D deficiency, supplement calcium intake, and support overall bone health in individuals at risk of low bone mineral density.
How does colecalciferol work in the body?+
Colecalciferol is converted in the liver and kidneys to the active hormone 1,25‑dihydroxyvitamin D, which binds to vitamin D receptors in target cells, enhancing intestinal absorption of calcium and phosphate and regulating bone remodeling processes.
What is the usual dose of Orotre?+
The appropriate dose of Orotre is determined by the prescribing healthcare professional based on the patient’s age, clinical condition, laboratory values, and overall nutritional needs. No standard regimen is provided here.
Is Orotre safe to use during pregnancy or breastfeeding?+
Use of Orotre during pregnancy or lactation should only occur under medical supervision. While vitamin D and calcium are essential nutrients, the prescriber must evaluate the risk‑benefit profile for each individual.
How do I order Orotre from GNH USA?+
To order Orotre, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and necessary import documentation.
How does Orotre compare with other vitamin D supplements?+
Orotre combines colecalciferol with calcium carbonate, offering both vitamin D and calcium in a single tablet. Stand‑alone vitamin D3 products provide only the hormone precursor, while separate calcium supplements lack the vitamin D component. The combination can simplify dosing for patients needing both nutrients.
What are the storage and handling requirements for Orotre?+
Store Orotre tablets at ambient temperature below 25 °C, in the original packaging, protected from moisture and direct light. Keep the container tightly closed and out of reach of children.
How is Orotre administered?+
Orotre is taken orally, usually with a glass of water. It can be taken with or without food, but taking it with meals may improve calcium absorption. Follow the prescriber’s instructions regarding frequency and duration.
What are the most serious risks associated with Orotre?+
The most serious risks include hypercalcemia, hypervitaminosis D, kidney stone formation, and severe allergic reactions. Patients should be monitored for signs such as persistent nausea, vomiting, muscle weakness, or unusual fatigue, and seek medical attention if they occur.
Who should not use Orotre?+
Individuals with known hypersensitivity to colecalciferol, calcium carbonate, or any excipients, as well as patients with existing hypercalcemia, severe renal impairment, or certain metabolic disorders, should avoid Orotre unless a healthcare professional advises otherwise.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Colecalciferol, Calcium Carbonate
Route
Oral Use
Manufacturer
Cheplapharm Arzneimittel Gmbh
Origin
EU

Related products